Lori Kunkel is a Current Board Member of Curis, Inc., Nurix Therapeutics, ORIC Pharmaceuticals, and Maverick Therapeutics.
Lori is a former Chief Medical Officer of Loxo Oncology, Pharmacyclics, and Proteolix and a former member of the Hematology/Oncology Unit at UCLA Medical.